MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies

Jun Liu1, Renxia Zhang, Fei Chen

  • 1Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Plos One
|October 3, 2013
PubMed
Abstract

Insights

The O(6)-methylguanine-DNA methyltransferase (MGMT) Leu84Phe polymorphism is linked to increased cancer risk, particularly lung cancer in Caucasians. This meta-analysis clarifies the association between this gene variant and cancer susceptibility.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • O(6)-methylguanine-DNA methyltransferase (MGMT) is crucial for DNA repair, directly reversing alkylating agent damage.
  • The MGMT Leu84Phe polymorphism has been investigated for its association with various cancer risks.
  • Previous studies yielded inconsistent results regarding the MGMT Leu84Phe polymorphism and cancer susceptibility.

Purpose of the Study:

  • To conduct a comprehensive meta-analysis of existing case-control studies.
  • To clarify the association between the MGMT Leu84Phe polymorphism and overall cancer risk.
  • To investigate potential ethnic and cancer-type specific associations.

Main Methods:

  • Meta-analysis of 44 independent case-control studies.
  • Statistical analysis of the MGMT Leu84Phe polymorphism (rs16906251) and cancer risk.
  • Subgroup analyses based on cancer type and ethnicity.

Main Results:

  • A significant association was found between the T allele (rs16906251) and increased cancer susceptibility under a recessive model (OR=1.30).
  • Increased lung cancer risk was observed, especially in Caucasians (TT vs CC, OR=1.67).
  • Colorectal cancer risk was significantly lower under a dominant model (OR=0.84), and no association was found in Asians.

Conclusions:

  • The MGMT Leu84Phe polymorphism is associated with susceptibility to certain cancers, notably lung cancer.
  • Ethnic differences in susceptibility exist, with a stronger association observed in Caucasian populations.
  • Further research is warranted to elucidate the precise role of MGMT genetic variations in cancer development.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...